Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Ciclix


9bis Rue Henri Chapu,
77300 Fontainebleau France

Contact : christian@ciclix.com

RUPPENTHAL Christian : président
COSTA NETO Edilberto : directeur
Web Site >

Logo Gene.iO small#Numeric Genomics #Diagnostic

  • stroke,
  • stroke protocol,
  • digital workflow,
  • hospital management,
  • collaboration tool

Field of Activity


Digital health, software for medical applications

Background

Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.
As a team, starting in 2018, Ciclix was early recognized for its technical skills when chosen by Alcatel-Lucent as the winner of their worldwide development competition.
Ciclix was recognized by the Brazilian National Private Hospitals Association as one of the top 12 most innovative health startups in Brazil and is currently in an internationalization process in the European Union.

Description of the Products / Services / Technology

StrokeHub is a mobile oriented application that uses state-of-the-art technology to synchronize the acute stroke protocol information with the stroke unit members in real-time.
Providing a visual representation of the protocol workflow as well as a communication channel for the entire team, StrokeHub is intuitive, easy to use and triggers faster decisions that allow more patients to get the right treatment in less time.

Customer references / Collaborations / Highlights

Centre Hospitalier Sud Francilien, Dr. Nicolas Chausson

Collaborations Sought
Hospitals for trials, market access, seed funding, investors.

  • More information

    STRENGTHS: Software engineering, product management, process digitalization.

    INNOVATION ASSETS:
    – VISUAL WORKFLOW (UI/UX DESIGN INNOVATION)
    The STROKEHUB team created a customized design that provides
    an intuitive way to interact with the stroke protocol.
    By using a visual representation of the protocol steps, every team
    member know exactly the past, ongoing and upcoming tasks.
    The container elements of the visual workflow allow either
    for getting information or for acting on ongoing stages.

    – LIVE PROTOCOL (DATA PROCESSING INNOVATION)
    By using a combination of cloud database infrastructure, data
    streams and algorithms, STROKEHUB synchronizes every minor
    step executed by a team member and propagates the information
    to the rest of the team to alow for live feedback in the app.
    No need to submit or refresh, everything is synchronized in real
    time meaning team members can engage in tasks that are
    currently in idle whitout worring about doing the work twice.

     

Share
Genopole’s Companies

#Diagnostic


In the same field

EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
SafeInsight - Entreprise génopolitaine

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover
Echoliv -Genopole's company

ECHOLIV

Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover
DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
logo GenoSplice - Genopole's Company

GenoSplice

Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).

Discover
Endodiag - Genopole's company

Endodiag

Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
AgenT Biotech - entreprise génopolitaine

AgenT

AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.

Discover
View all >
With the support from